Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Drug Dev Res
2001 Aug 01;534:281-291. doi: 10.1002/ddr.1197.
Show Gene links
Show Anatomy links
Actions of a Series of PPADS Analogs at P2X1 and P2X3 Receptors.
Brown SG
,
Kim YC
,
Kim SA
,
Jacobson KA
,
Burnstock G
,
King BF
.
???displayArticle.abstract???
[Table: see text] Seven PPADS (Pyridoxal-5'-Phosphate 6-Azophenyl 2',4'-DiSulfonate) analogs were investigated at Group 1 P2X receptors expressed in Xenopus oocytes. All seven analogs potently inhibited P2X1 (IC50 range, 5-32 nM) and P2X3 (IC50 range, 22-345 nM), the two Group I P2X receptor subtypes. Analogs showed greater inhibitory activity where the pyridoxal moiety of PPADS contained a 5'-phosphonate group, rather than a 5'-phosphate group. Analogs also showed greater potency where disulfonate groups were removed from, or substituted at, the azophenyl moiety. The most active analog was MRS 2257 (pyridoxal-5'-phosphonate 6-azophenyl 3',5'-bismethylenephosphonate) at P2X1 (IC50, 5 nM) and P2X3 (IC50, 22 nM) receptors, being 14-fold and 10-fold more potent than PPADS itself. MRS 2257 produced a nonsurmountable inhibition when tested against a range of ATP concentrations, although blockade was reversed by about 85% after 20 minutes of washout. TNP-ATP and Ip5I were equipotent with MRS 2257 at P2X1 receptors, whereas TNP-ATP was 64-fold more potent than MRS 2257 at P2X3 receptors. In conclusion, the PPADS template can be altered at the pyridoxal and phenyl moieties to produce P2X1 and P2X3 receptor antagonists showing higher potency and greater degree of reversibility than the parent compound at these Group I P2X receptors.
???displayArticle.pubmedLink???
27134334
???displayArticle.pmcLink???PMC4851439 ???displayArticle.link???Drug Dev Res ???displayArticle.grants???[+]
Boyer,
Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
1994, Pubmed
Boyer,
Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
1994,
Pubmed
Brown,
PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors.
1995,
Pubmed
Chen,
Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages.
1996,
Pubmed
Hoffmann,
Inhibition of Ecto-Apyrase and Ecto-ATPase by Pyridoxal Phosphate-Related Compounds.
2000,
Pubmed
Hoyle,
Antagonism of P2X receptors in guinea-pig vas deferens by diinosine pentaphosphate.
1997,
Pubmed
Jacobson,
Molecular recognition in P2 receptors: ligand development aided by molecular modeling and mutagenesis.
1999,
Pubmed
Jacobson,
A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
1998,
Pubmed
,
Xenbase
Khakh,
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.
2001,
Pubmed
Kim,
Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists.
1998,
Pubmed
,
Xenbase
Kim,
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
2001,
Pubmed
,
Xenbase
King,
Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors.
1999,
Pubmed
,
Xenbase
King,
A novel P1 purinoceptor activates an outward K+ current in follicular oocytes of Xenopus laevis.
1996,
Pubmed
,
Xenbase
King,
Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor.
1997,
Pubmed
,
Xenbase
King,
P2 purinoceptor-activated inward currents in follicular oocytes of Xenopus laevis.
1996,
Pubmed
,
Xenbase
Lambrecht,
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors.
2000,
Pubmed
,
Xenbase
Lambrecht,
PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.
1992,
Pubmed
Lewis,
2',3'-O-(2,4,6- trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP)--a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels.
1998,
Pubmed
McLaren,
Investigation of the actions of PPADS, a novel P2x-purinoceptor antagonist, in the guinea-pig isolated vas deferens.
1994,
Pubmed
Ralevic,
Receptors for purines and pyrimidines.
1998,
Pubmed
Schachter,
Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
1996,
Pubmed
Trezise,
The use of antagonists to characterize the receptors mediating depolarization of the rat isolated vagus nerve by alpha, beta-methylene adenosine 5'-triphosphate.
1994,
Pubmed
Trezise,
P2 purinoceptor antagonist properties of pyridoxal-5-phosphate.
1994,
Pubmed
Virginio,
Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors.
1998,
Pubmed
Williams,
Purinergic and pyrimidinergic receptors as potential drug targets.
2000,
Pubmed
Windscheif,
Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptors.
1994,
Pubmed
Windscheif,
Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum.
1995,
Pubmed
Windscheif,
Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregation.
1995,
Pubmed
Ziganshin,
PPADS selectively antagonizes P2X-purinoceptor-mediated responses in the rabbit urinary bladder.
1993,
Pubmed
Ziganshin,
Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevis.
1996,
Pubmed
,
Xenbase
Ziganshin,
Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown.
1995,
Pubmed
,
Xenbase
Ziganshin,
Selective antagonism by PPADS at P2X-purinoceptors in rabbit isolated blood vessels.
1994,
Pubmed
